Literature DB >> 6267040

Interaction of calmodulin with myosin light chain kinase and cAMP-dependent protein kinase in bovine brain.

D R Hathaway, R S Adelstein, C B Klee.   

Abstract

Myosin light chain kinase and a fraction of type II cAMP-dependent protein kinase have been partially purified from bovine brain by affinity chromatography on calmodulin-Sepharose. The myosin kinase was purified approximately 3700-fold and has an estimated molecular weight of 130,000 +/- 10,000 by sodium dodecyl sulfate gel electrophoresis. A fraction of soluble cAMP-dependent protein kinase also bound to calmodulin-Sepharose and was purified 2300-fold. A fraction of this cAMP-dependent protein kinase after purification by glycerol gradient centrifugation was shown to contain the two subunits of calcineurin, a major calmodulin-binding protein in brain, and the two subunits of type II cAMP-dependent protein kinase in a ratio of 1:1:2:2. Its sedimentation coefficient was 8.1 S and 9.0 S when centrifuged in the absence or presence of calmodulin, suggesting the formation of a complex between calmodulin and protein kinase. Our results suggest the possibility that calcineurin may be involved in the interaction between the protein kinase and calmodulin. Furthermore, our studies imply that the regulatory subunit of the cAMP-dependent protein kinase, but not the catalytic subunit, is the site of interaction with calmodulin since the catalytic subunit of protein kinase was partially resolved from the complex by cAMP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  A high-affinity calmodulin-binding site in a tobacco plasma-membrane channel protein coincides with a characteristic element of cyclic nucleotide-binding domains.

Authors:  T Arazi; B Kaplan; H Fromm
Journal:  Plant Mol Biol       Date:  2000-03       Impact factor: 4.076

2.  Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells.

Authors:  J L Meinkoth; Y Ji; S S Taylor; J R Feramisco
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Phosphorylation of smooth muscle myosin by type II Ca2+/calmodulin-dependent protein kinase.

Authors:  A M Edelman; W H Lin; D J Osterhout; M K Bennett; M B Kennedy; E G Krebs
Journal:  Mol Cell Biochem       Date:  1990-09-03       Impact factor: 3.396

Review 4.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Insulin stimulates the generation of an adipocyte phosphoprotein that is isolated with a monoclonal antibody against the regulatory subunit of bovine heart cAMP-dependent protein kinase.

Authors:  J C Lawrence; J F Hiken; M Inkster; C W Scott; M C Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Evidence against direct involvement of cyclic AMP-dependent protein phosphorylation in the exocytosis of amylase.

Authors:  T Takuma
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

Review 7.  A molecular description of nerve terminal function.

Authors:  L F Reichardt; R B Kelly
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

8.  High-affinity binding of the regulatory subunit (RII) of cAMP-dependent protein kinase to microtubule-associated and other cellular proteins.

Authors:  S M Lohmann; P DeCamilli; I Einig; U Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

Review 9.  Calmodulin.

Authors:  Y M Lin
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

10.  Frozen tissue sections as an experimental system to reveal specific binding sites for the regulatory subunit of type II cAMP-dependent protein kinase in neurons.

Authors:  P Miller; U Walter; W E Theurkauf; R B Vallee; P De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.